StemRIM

About

StemRIM is a bio company that aims to develop "regeneration-inducing medicines".

Osaka,Osaka,Japan
51 - 100

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: ¥745.02M
Industries: Biotechnology,Medical,Product Research
Founded date: Oct 30, 2006
Number Of Employee: 51 - 100
Operating Status: Active
Stock Symbol: tyo:4599
Legal Name: Stem Rim Co., Ltd.
Also Known As: 株式会社ステムリム

Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

¥3.44B

StemRIM has raised a total of ¥3.44B in funding over 2 rounds. Their latest funding was raised on Aug 9, 2019 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 9, 2019	IPO	—	—	—	—	Detail
Dec 28, 2018	Series Unknown	¥745.02M	6	—	—	Detail
Dec 7, 2018	Series Unknown	¥699.93M	1	DCI Partners	—	Detail
Dec 15, 2017	Series Unknown	¥199.98M	1	Mitsubishi UFJ Capital	—	Detail
Nov 17, 2017	Series Unknown	¥1B	10	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

13

StemRIM is funded by 13 investors. DCI Partners and Mitsubishi UFJ Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
DCI Partners	Yes	Series Unknown
Mitsubishi UFJ Capital	Yes	Series Unknown
Shionogi	Yes	Corporate Round
M3i	—	Series Unknown
KSP	—	Series Unknown
Kyogin Lease & Capital	—	Series Unknown
M3	—	Series Unknown
Miyako Capital	—	Series Unknown
SMBC Venture Capital	—	Series Unknown
Mizuho Capital	—	Series Unknown